Breaking News Instant updates and real-time market news.

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

, AMGN

Amgen

$177.08

2.21 (1.26%)

12:51
07/15/19
07/15
12:51
07/15/19
12:51

Piper reiterates Overweight on Cytokinetics after completion of trial enrollment

Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $14 price target on Cytokinetics (CYTK) after Amgen (AMGN) completed enrollment of more than 8,200 Heart Failure patients in its Phase III GALACTIC-HF trial of omecamtiv mecarbil. The analyst anticipates an interim GALACTIC-HF efficacy analysis in 2020, with final data likely in 2021.

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

AMGN

Amgen

$177.08

2.21 (1.26%)

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

CYTK Cytokinetics
$11.04

0.02 (0.18%)

02/20/19
PIPR
02/20/19
NO CHANGE
Target $12
PIPR
Overweight
Piper reiterates Overweight rating on Cytokinetics after Amgen starts study
After Cytokinetics (CYTK) announced that partner Amgen (AMGN) has initiated a Phase 1 study of cardiac troponin activator AMG 594, Piper Jaffray analyst Edward Tenthoff said he envisions the two developing AMG 594 in heart failure with reduced ejection fraction, or HFrEF. The analyst, who noted he awaits the futility analysis of the Phase 3 GALACTIC-HF trial of omecamtiv mecarbil in HFrEF patients, which is expected to be reported in the first half of the year, reiterated an Overweight rating and $12 price target on Cytokinetics shares.
03/20/19
PIPR
03/20/19
NO CHANGE
PIPR
Cytokinetics price target raised to $13 from $12 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating on Cytokinetics and raised his price target on shares to $13 from $12 after Cytokinetics and its partners announced that omecamtiv mecarbil has passed a futility analysis in the Phase III GALACTIC-HF trial, which will continue enrolling ~8,000 HFrEF patients. The analyst anticipates an interim efficacy analysis in 2020, prior to final data likely in 2021.
05/06/19
HCWC
05/06/19
NO CHANGE
Target $26
HCWC
Buy
Cytokinetics price target raised to $26 from $21 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Cytokinetics to $26 from $21 and keeps a Buy rating on the shares. While the Phase 2 trial testing reldesemtiv in patients with amyotrophic lateral sclerosis missed its endpoint misses, reldesemtiv activity was "clear and broad,: setting up the next steps, Pantginis tells investors in a research note titled "Bad Headline, Impressive Data; Reldesemtiv Effects Consistent; Target Increased to $26." The analyst believes the data show important characteristics of reldesemtiv, including comparable effects across all doses, consistent effects across all timepoints, and durability of the effects.
05/06/19
PIPR
05/06/19
NO CHANGE
Target $14
PIPR
Overweight
Cytokinetics' reldesemtiv appears active despite trial miss, says Piper Jaffray
While Cytokinetics' Phase III data for reldesemtiv missed the primary endpoint of slow vital capacity at 12 weeks, the drug did show benefits over placebo in amyotrophic lateral sclerosis, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. He points out the company intends to advance reldesemtiv into a Phase III ALS trial. The analyst reiterates an Overweight rating on Cytokinetics and boosted his price target for the shares to $14 from $13.
AMGN Amgen
$177.08

2.21 (1.26%)

06/04/19
RHCO
06/04/19
NO CHANGE
Target $120
RHCO
Buy
Mirati Therapeutics price target raised to $120 from $85 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Mirati Therapeutics (MRTX) to $120 and kept his Buy rating following yesterday's "encouraging" ASCO presentation by Amgen (AMGN) regarding its KRAS G12C inhibitor AMG 510. The analyst notes that the side effect profile and response to the treatment's lowest dose in AMG 510 are positive for Mirati's MRTX849, raising his probability Adjusted Peak Sales for the latter to $1.65B from $1.33B with probability of success little changed at 52%.
06/05/19
LEHM
06/05/19
NO CHANGE
Target $123
LEHM
Overweight
Mirati Therapeutics price target raised to $123 from $85 at Barclays
Barclays analyst Gena Wang raised her price target for Mirati Therapeutics (MRTX) to $123 from $85 saying Amgen's (AMGN) AMG510 data support KRAS G12C as a validated target, and the "impressive" data provide proof of concept for potentially single agent activity in non-small cell lung cancer. The analyst continues to believe that Mirati's MRTX849 could have a more favorable profile based on the preclinical results, including "longer half-life and good tissue penetration." She reiterates an Overweight rating on Mirati Therapeutics.
06/05/19
HCWC
06/05/19
NO CHANGE
Target $117
HCWC
Buy
Mirati Therapeutics price target raised to $117 from $84 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for Mirati Therapeutics (MRTX) to $117 from $84 saying the positive data for Amgen's (AMGN) AMG 510 bode well for Mirati's MRTX849. The analyst believes the AMG 510 data "somewhat derisks" the development of MRTX849/ He raised his estimate for probability of success for MRTX849 to 20% from 10% and keeps a Buy rating on Mirati Therapeutics.
06/07/19
GUGG
06/07/19
DOWNGRADE
GUGG
Neutral
Guggenheim downgrades Mirati to Neutral following near-tripling of stock
As previously reported, Guggenheim analyst Michael Schmidt downgraded Mirati Therapeutics (MRTX) to Neutral from Buy, noting that the shares have nearly tripled since data were presented at the European Society for Medical Oncology, or ESMO, meeting in October. While Schmidt said Amgen's (AMGN) KRAS inhibitor Phase I data presented at the American Society of Clinical Oncology meeting validates MRTX849's potential mechanism of action, he sees a "lot of upside" priced in at the current valuation despite the remaining development risks. He also believes investor expectations have significantly increased ahead of Mirati's own Phase I data presentation in the second half of the year.

TODAY'S FREE FLY STORIES

BAC

Bank of America

$30.12

0.44 (1.48%)

, TPR

Tapestry

$25.16

-0.43 (-1.68%)

19:46
09/15/19
09/15
19:46
09/15/19
19:46
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

BAC

Bank of America

$30.12

0.44 (1.48%)

TPR

Tapestry

$25.16

-0.43 (-1.68%)

T

AT&T

$37.90

-0.46 (-1.20%)

UHAL

Amerco

$379.63

4.21 (1.12%)

GM

General Motors

$38.83

-0.22 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 16

    Oct

  • 23

    Oct

GM

General Motors

$38.83

-0.22 (-0.56%)

19:23
09/15/19
09/15
19:23
09/15/19
19:23
Hot Stocks
President Trump urges General Motors, UAW to resolve contract dispute »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBCI

Glacier Bancorp

$41.37

0.43 (1.05%)

17:04
09/15/19
09/15
17:04
09/15/19
17:04
Conference/Events
Glacier Bancorp management to meet with Janney Montgomery Scott »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 06

    Nov

16:55
09/15/19
09/15
16:55
09/15/19
16:55
Conference/Events
SunTrust retail/consumer goods analysts to hold a dinner meeting »

Retail/Consumer Goods…

16:55
09/15/19
09/15
16:55
09/15/19
16:55
Conference/Events
SunTrust retail analyst team to hold a dinner meeting »

The Retail/Consumer Goods…

T

AT&T

$37.90

-0.46 (-1.20%)

, CMCSA

Comcast

$46.89

-0.08 (-0.17%)

16:54
09/15/19
09/15
16:54
09/15/19
16:54
On The Fly
Box Office Battle: 'It: Chapter Two' wins weekend again with $40.8M »

"Box Office Battle" is…

T

AT&T

$37.90

-0.46 (-1.20%)

CMCSA

Comcast

$46.89

-0.08 (-0.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$60.37

0.06 (0.10%)

LGF.A

Lionsgate

$11.15

-0.065 (-0.58%)

LGF.B

Lionsgate

$10.44

-0.1 (-0.95%)

DIS

Disney

$138.00

0.44 (0.32%)

VIAB

Viacom

$26.05

0.02 (0.08%)

VIA

Viacom

$28.01

-0.1 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

BA

Boeing

$379.87

4.3 (1.14%)

16:34
09/15/19
09/15
16:34
09/15/19
16:34
Periodicals
Boeing board to call for safety changes following 737 Max crashes, NYTimes says »

For the past five months,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FB

Facebook

$186.97

-0.42 (-0.22%)

16:25
09/15/19
09/15
16:25
09/15/19
16:25
Periodicals
Regulators to question Facebook's Libra amid EU concerns, FT reports »

Facebook will be quizzed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

AAPL

Apple

$218.71

-4.4 (-1.97%)

16:22
09/15/19
09/15
16:22
09/15/19
16:22
Periodicals
Apple TV+ premieres with period drama at Tribeca Festival, Reuters reports »

Apple TV+ premiered its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$42.01

-0.77 (-1.80%)

, BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

16:19
09/15/19
09/15
16:19
09/15/19
16:19
Periodicals
New York bans flavored e-cigarettes, Reuters reports »

New York Governor Andrew…

MO

Altria Group

$42.01

-0.77 (-1.80%)

BTI

British American Tobacco

$36.76

-1.21 (-3.19%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$73.01

-1.89 (-2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SPY

SPDR S&P 500 ETF Trust

$300.98

-0.29 (-0.10%)

, SPX

S&P 500

$0.00

(0.00%)

15:52
09/15/19
09/15
15:52
09/15/19
15:52
Periodicals
Spare oil capacity in U.S. hands after Saudi outage, Reuters says »

An attack on Saudi oil…

SPY

SPDR S&P 500 ETF Trust

$300.98

-0.29 (-0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENRFF

Enerflex

$0.00

(0.00%)

15:52
09/15/19
09/15
15:52
09/15/19
15:52
Conference/Events
Enerflex management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SNMSF

Spin Master

$0.00

(0.00%)

15:50
09/15/19
09/15
15:50
09/15/19
15:50
Conference/Events
Spin Master management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 12

    Nov

WFTBF

West Fraser Timber

$0.00

(0.00%)

15:48
09/15/19
09/15
15:48
09/15/19
15:48
Conference/Events
West Fraser Timber management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

GM

General Motors

$38.83

-0.22 (-0.56%)

15:41
09/15/19
09/15
15:41
09/15/19
15:41
Periodicals
UAW calls strike against GM amid financial crisis, CNBC reports »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOD

Kodiak Sciences

$14.99

0.805 (5.68%)

15:34
09/15/19
09/15
15:34
09/15/19
15:34
Hot Stocks
Kodiak Sciences announces emerging durability data from Phase 1 study of KSI-301 »

Kodiak Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

LHX

L3Harris Technologies

$207.62

-1.88 (-0.90%)

, ESLT

Elbit Systems

$157.40

-0.2 (-0.13%)

15:30
09/15/19
09/15
15:30
09/15/19
15:30
Hot Stocks
L3Harris Technologies completes sale of Harris Night Vision business »

L3Harris Technologies…

LHX

L3Harris Technologies

$207.62

-1.88 (-0.90%)

ESLT

Elbit Systems

$157.40

-0.2 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAYRY

Bayer

$0.00

(0.00%)

, BJ

BJ's Wholesale

$27.45

-0.02 (-0.07%)

12:56
09/15/19
09/15
12:56
09/15/19
12:56
Conference/Events
Shoptalk to hold a conference »

Grocery Shop to be held…

BAYRY

Bayer

$0.00

(0.00%)

BJ

BJ's Wholesale

$27.45

-0.02 (-0.07%)

BMBOY

Grupo Bimbo

$0.00

(0.00%)

FB

Facebook

$186.97

-0.42 (-0.22%)

FORR

Forrester

$36.33

0.38 (1.06%)

HAIN

Hain Celestial

$21.97

0.25 (1.15%)

HSY

Hershey

$148.68

-2.445 (-1.62%)

IBM

IBM

$143.59

-0.01 (-0.01%)

K

Kellogg

$63.36

-0.33 (-0.52%)

MDLZ

Mondelez

$54.08

-0.7 (-1.28%)

NLSN

Nielsen

$22.45

-0.06 (-0.27%)

PG

Procter & Gamble

$122.11

-0.68 (-0.55%)

PJC

Piper Jaffray

$78.23

-0.39 (-0.50%)

REV

Revlon

$19.86

0.02 (0.10%)

SJM

J.M. Smucker

$106.51

0.72 (0.68%)

TGT

Target

$108.01

-0.92 (-0.84%)

TSN

Tyson Foods

$85.19

1.71 (2.05%)

UL

Unilever; also tag UN

$61.15

-0.52 (-0.84%)

WMT

Walmart

$117.40

0.42 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 15

    Sep

  • 17

    Sep

  • 19

    Sep

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 08

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

NVCR

Novocure

$79.29

-0.92 (-1.15%)

, RHHBY

Roche

$0.00

(0.00%)

12:54
09/15/19
09/15
12:54
09/15/19
12:54
Conference/Events
American Society for Radiation Oncology to hold annual meeting »

2019 ASTRO Annual Meeting…

NVCR

Novocure

$79.29

-0.92 (-1.15%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$43.72

-0.11 (-0.25%)

SIEGY

Siemens

$0.00

(0.00%)

TDY

Teledyne

$315.15

2.75 (0.88%)

VAR

Varian Medical

$117.39

-2.19 (-1.83%)

HTHIY

Hitachi

$0.00

(0.00%)

GHDX

Genomic Health

$71.69

-1.02 (-1.40%)

ESALY

Eisai

$0.00

(0.00%)

EKTAY

Elekta

$0.00

(0.00%)

BMY

Bristol-Myers

$49.40

-0.22 (-0.44%)

BSX

Boston Scientific

$41.81

-0.42 (-0.99%)

BAYRY

Bayer

$0.00

(0.00%)

AZN

AstraZeneca

$42.76

-0.14 (-0.33%)

ARAY

Accuray

$3.03

(0.00%)

MRK

Merck

$82.61

0.38 (0.46%)

MDT

Medtronic

$109.63

-0.77 (-0.70%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

HOLX

Hologic

$49.72

-0.09 (-0.18%)

ISR

IsoRay

$0.32

-0.0059 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 15

    Sep

  • 16

    Sep

  • 16

    Sep

  • 16

    Sep

  • 16

    Sep

  • 18

    Sep

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 10

    Oct

  • 23

    Oct

  • 29

    Oct

  • 31

    Oct

  • 04

    Nov

  • 13

    Nov

12:50
09/15/19
09/15
12:50
09/15/19
12:50
Conference/Events
SunTrust retail analyst team to hold a dinner meeting »

The Retail/Consumer Goods…

NET

Cloudflare

$17.96

(0.00%)

, AMZN

Amazon.com

$1,837.49

-6 (-0.33%)

07:40
09/15/19
09/15
07:40
09/15/19
07:40
On The Fly
Opening Day: Cloudflare jumps in market debut »

Shares of Cloudflare…

NET

Cloudflare

$17.96

(0.00%)

AMZN

Amazon.com

$1,837.49

-6 (-0.33%)

MSFT

Microsoft

$137.21

-0.33 (-0.24%)

STSA

Satsuma Pharmaceuticals

$16.61

(0.00%)

SWTX

SpringsWorks Therapeutics

$22.75

(0.00%)

SDC

SmileDirectClub

$18.68

1.8 (10.66%)

TXG

10x Genomics

$53.80

0.85 (1.61%)

PTON

Peloton

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

NVST

Envista

$0.00

(0.00%)

XGN

Exagen

$0.00

(0.00%)

DDOG

Datadog

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

NDAQ

Nasdaq

$99.51

0.5 (0.51%)

DHR

Danaher

$141.02

-0.84 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 17

    Sep

  • 17

    Sep

  • 27

    Oct

  • 07

    Nov

  • 18

    Sep

  • 19

    Sep

  • 26

    Sep

04:55
09/15/19
09/15
04:55
09/15/19
04:55
Conference/Events
SunTrust retail/consumer goods analysts to hold a dinner meeting »

Retail/Consumer Goods…

ABT

Abbott

$84.25

-0.96 (-1.13%)

, ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

13:22
09/14/19
09/14
13:22
09/14/19
13:22
Conference/Events
William Blair diagnostic products/med tech analyst to hold a group luncheon »

Diagnostic Products &…

ABT

Abbott

$84.25

-0.96 (-1.13%)

ADPT

Adaptive Biotechnologies

$43.28

3.49 (8.77%)

BDX

Becton Dickinson

$260.68

-1.41 (-0.54%)

COO

Cooper Companies

$301.95

-3 (-0.98%)

EXAS

Exact Sciences

$106.72

-1.99 (-1.83%)

GH

Guardant Health

$77.54

0.49 (0.64%)

NEO

NeoGenomics

$21.34

-1.22 (-5.41%)

LMNX

Luminex

$22.62

0.1 (0.44%)

HAE

Haemonetics

$125.55

-0.31 (-0.25%)

STAA

STAAR Surgical

$29.21

0.415 (1.44%)

QGEN

Qiagen

$33.97

-0.105 (-0.31%)

NVTA

Invitae

$21.70

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 13

    Nov

  • 05

    Dec

CRTO

Criteo

, TWTR

Twitter

13:19
09/14/19
09/14
13:19
09/14/19
13:19
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

Technology & Internet…

CRTO

Criteo

TWTR

Twitter

SNAP

Snap

GOOGL

Alphabet Class A

FB

Facebook

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

T

AT&T

$37.90

-0.46 (-1.20%)

09:06
09/14/19
09/14
09:06
09/14/19
09:06
Periodicals
AT&T stock already benefiting from activist involvement, Barron's says »

AT&T 's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.